p.130 抽出テキスト
166. Litmanovich D, Bankier AA, Cantin L, Raptopoulos V, Boiselle PM. CT and MRI in diseases of the aorta. AJR Am J Roentgenol 2009;193:928–40. https://doi.org/10.2214/ajr. 08.2166 167. Pennell DJ, Sechtem UP, Higgins CB, Manning W, Pohost G, Rademakers F, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. J Cardiovasc Magn Reson 2004;6:727–65. https://doi.org/10.1081/jcmr- 200038581 168. Yoshioka K, Tanaka R. MRI and MRA of aortic disease. Ann Vasc Dis 2010;3:196–201. https://doi.org/10.3400/avd.sasdi10003 169. Fadel BM, Mohty D, Kazzi BE, Alamro B, Arshi F, Mustafa M, et al. Ultrasound imaging of the abdominal aorta: a comprehensive review. J Am Soc Echocardiogr 2021;34:1119–36. https://doi.org/10.1016/j.echo.2021.06.012 170. Bhave NM, Nienaber CA, Clough RE, Eagle KA. Multimodality imaging of thoracic aortic diseases in adults. JACC Cardiovasc Imaging 2018;11:902–19. https://doi.org/10.1016/ j.jcmg.2018.03.009 171. Goldstein SA, Evangelista A, Abbara S, Arai A, Asch FM, Badano LP, et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American Society of Echocardiography and the European Association of Cardiovascular Imaging: endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2015;28:119–82. https:// doi.org/10.1016/j.echo.2014.11.015 172. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873–926. https://doi.org/10.1093/eurheartj/ ehu281 173. Bossone E, Czerny M, Lerakis S, Rodríguez-Palomares J, Kukar N, Ranieri B, et al. Imaging and biomarkers in acute aortic syndromes: diagnostic and prognostic implications. Curr Probl Cardiol 2021;46:100654. https://doi.org/10.1016/j.cpcardiol.2020. 100654 174. Bossone E, LaBounty TM, Eagle KA. Acute aortic syndromes: diagnosis and management, an update. Eur Heart J 2018;39:739–49d. https://doi.org/10.1093/eurheartj/ ehx319 175. Vardhanabhuti V, Nicol E, Morgan-Hughes G, Roobottom CA, Roditi G, Hamilton MCK, et al. Recommendations for accurate CT diagnosis of suspected acute aortic syndrome (AAS)—on behalf of the British Society of Cardiovascular Imaging (BSCI)/ British Society of Cardiovascular CT (BSCCT). Br J Radiol 2016;89:20150705. https://doi.org/10.1259/bjr.20150705 176. Carstensen M, Keer D, Rempel J, Jeon P, Barrett B. Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies. Can Assoc Radiol J 2012;63: 177–82. https://doi.org/10.1016/j.carj.2010.12.004 177. Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med 2007;357:2277–84. https://doi.org/10.1056/NEJMra072149 178. Barra L, Kanji T, Malette J, Pagnoux C. Imaging modalities for the diagnosis and disease activity assessment of Takayasu’s arteritis: a systematic review and meta-analysis. Autoimmun Rev 2018;17:175–87. https://doi.org/10.1016/j.autrev.2017.11.021 179. Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhäll C-J, Ebbers T, et al. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson 2015; 17:72. https://doi.org/10.1186/s12968-015-0174-5 180. Rodriguez-Palomares JF. Genetics of bicuspid aortic valve: ready for clinical use? Heart 2022;108:1078–9. https://doi.org/10.1136/heartjnl-2021-320742 181. Guala A, Teixido-Tura G, Dux-Santoy L, Granato C, Ruiz-Muñoz A, Valente F, et al. Decreased rotational flow and circumferential wall shear stress as early markers of descending aorta dilation in Marfan syndrome: a 4D flow CMR study. J Cardiovasc Magn Reson 2019;21:63. https://doi.org/10.1186/s12968-019-0572-1 182. Horowitz MJ, Kupsky DF, El-Said HG, Alshawabkeh L, Kligerman SJ, Hsiao A. 4D flow MRI quantification of congenital shunts: comparison to invasive catheterization. Radiol Cardiothorac Imaging 2021;3:e200446. https://doi.org/10.1148/ryct.2021200446 183. Rizk J. 4D flow MRI applications in congenital heart disease. Eur Radiol 2021;31: 1160–74. https://doi.org/10.1007/s00330-020-07210-z 184. Gupta SK, Ya’qoub L, Wimmer AP, Fisher S, Saeed IM. Safety and clinical impact of MRI in patients with non-MRI-conditional cardiac devices. Radiol Cardiothorac Imaging 2020; 2:e200086. https://doi.org/10.1148/ryct.2020200086 185. Munawar DA, Chan JEZ, Emami M, Kadhim K, Khokhar K, O’Shea C, et al. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverterdefibrillators: a systematic review and meta-analysis. Europace 2020;22:288–98. https://doi.org/10.1093/europace/euz343 186. Nienaber CA. The role of imaging in acute aortic syndromes. Eur Heart J Cardiovasc Imaging 2013;14:15–23. https://doi.org/10.1093/ehjci/jes215 187. van der Geest KSM, Treglia G, Glaudemans A, Brouwer E, Sandovici M, Jamar F, et al. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2021;48: 3886–902. https://doi.org/10.1007/s00259-021-05362-8 188. Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018;77:636–43. https://doi.org/10.1136/annrheumdis-2017-212649 189. Forsythe RO, Dweck MR, McBride OMB, Vesey AT, Semple SI, Shah ASV, et al. (18) F-sodium fluoride uptake in abdominal aortic aneurysms: the SoFIA(3) study. J Am Coll Cardiol 2018;71:513–23. https://doi.org/10.1016/j.jacc.2017.11.053 190. Roque A, Pizzi MN. (18)F-FDG PET/CT: not only a promise for complex scenarioslet’s talk about aortic grafts. J Nucl Cardiol 2022;29:2949–51. https://doi.org/10.1007/ s12350-021-02888-0 191. Roque A, Pizzi MN, Fernández-Hidalgo N, Permanyer E, Cuellar-Calabria H, Romero-Farina G, et al. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: ‘normality’ is a possible diagnosis. Eur Heart J Cardiovasc Imaging 2020;21:24–33. https://doi.org/10.1093/ehjci/jez222 192. Pizzi MN, Roque A, Cuéllar-Calabria H, Fernández-Hidalgo N, Ferreira-González I, González-Alujas MT, et al. (18)F-FDG-PET/CTA of prosthetic cardiac valves and valvetube grafts: infective versus inflammatory patterns. JACC Cardiovasc Imaging 2016;9: 1224–7. https://doi.org/10.1016/j.jcmg.2016.05.013 193. Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 2015;132:1113–26. https://doi.org/10.1161/ circulationaha.115.015316 194. Teraa M, Hazenberg CE, Houben IB, Trimarchi S, van Herwaarden JA. Important issues regarding planning and sizing for emergent TEVAR. J Cardiovasc Surg (Torino) 2020;61: 708–12. https://doi.org/10.23736/S0021-9509.20.11571-4 195. Lindholt JS, Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017;390:2256–65. https://doi.org/10.1016/S0140-6736(17)32250-X 196. Lin JS, Evans CV, Johnson E, Redmond N, Coppola EL, Smith N. Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US preventive services task force. JAMA 2018;320:281–97. https:// doi.org/10.1001/jama.2018.4242 197. Normahani P, Burgess L, Norrie J, Epstein DM, Kandiyil N, Saratzis A, et al. Study protocol for a multicentre comparative diagnostic accuracy study of tools to establish the presence and severity of peripheral arterial disease in people with diabetes mellitus: the DM PAD study. BMJ Open 2022;12:e066950. https://doi.org/10.1136/ bmjopen-2022-066950 198. Ueshima D, Barioli A, Nai Fovino L, D’Amico G, Fabris T, Brener SJ, et al. The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2020;95: 993–1000. https://doi.org/10.1002/ccd.28335 199. de Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB, O’Leary DH, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke 2010;41:1294–7. https://doi.org/10.1161/ STROKEAHA.110.581058 200. Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for asymptomatic carotid artery stenosis: US preventive services task force recommendation statement. JAMA 2021;325:476–81. https://doi.org/10.1001/jama. 2020.26988 201. AbuRahma AF, Avgerinos ED, Chang RW, Darling RC, Duncan AA, Forbes TL, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg 2022;75:4S–22S. https://doi.org/10.1016/j.jvs.2021. 04.073 202. Howard DPJ, Gaziano L, Rothwell PM. Risk of stroke in relation to degree of asymptomatic carotid stenosis: a population-based cohort study, systematic review, and meta-analysis. Lancet Neurol 2021;20:193–202. https://doi.org/10.1016/s1474- 4422(20)30484-1 203. Paraskevas KI, Spence JD, Mikhailidis DP, Antignani PL, Gloviczki P, Eckstein H-H, et al. Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial. Int J Cardiol 2023;371:406–12. https://doi.org/10.1016/j.ijcard.2022.09.045 204. Kobo O, Saada M, von Birgelen C, Tonino PAL, Íñiguez-Romo A, Fröbert O, et al. Impact of multisite artery disease on clinical outcomes after percutaneous coronary intervention: an analysis from the e-Ultimaster registry. Eur Heart J Qual Care Clin Outcomes 2023;9:417–26. https://doi.org/10.1093/ehjqcco/qcac043 205. Steffel J, Eikelboom JW, Anand SS, Shestakovska O, Yusuf S, Fox KAA. The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease. Circulation 2020;142:40–8. https://doi.org/10. 1161/CIRCULATIONAHA.120.046048 206. Del Giorno R, Reveilhac M, Stauffer I, Berthoud M, Mazzolai L, Depairon M, et al. A new score for improving cardiovascular risk prediction and prevention. Nutr Metab Cardiovasc Dis 2023;33:1546–55. https://doi.org/10.1016/j.numecd.2023.04.019 207. Mehta A, Rigdon J, Tattersall MC, German CA, Barringer TA, Joshi PH, et al. Association of carotid artery plaque with cardiovascular events and incident coronary ESC Guidelines 3667 Downloaded from academic.oup.com/eurheartj/article/45/36/3538/7738955 by guest on 07 October 2026